Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels-Reference-Cited by-同舟云学术

Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels

Published:2019-08-12 Issue:8 Volume:15 Page:e1007223
ISSN:1553-7358
Container-title:PLOS Computational Biology
language:en
Short-container-title:PLoS Comput Biol

Author:

Scire Jérémie^ORCID,Hozé Nathanaël^ORCID,Uecker Hildegard^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modelling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference56 articles.

1. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America;HW Boucher;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2009

2. The emergence of pan-resistant gram-negative pathogens merits a rapid global political response;TR Walsh;Journal of Antimicrobial Chemotherapy,2012

3. Centres for Disease Control and Prevention (US). Antibiotic resistance threats in the United States, 2013. Centres for Disease Control and Prevention, US Department of Health and Human Services; 2013.

4. Tackling drug-resistant infections globally: final report and recommendations;J O’Neill;Review on Antimicrobial Resistance,2016

5. The path of least resistance: aggressive or moderate treatment?;RD Kouyos;Proceedings of the Royal Society B: Biological Sciences,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance;PLOS Computational Biology;2023-08-14

2. A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance;2023-02-21

3. Nanotechnology-Based Promising Therapeutic Approaches Against Protozoan;Pathobiology of Parasitic Protozoa: Dynamics and Dimensions;2023

4. Suppressing evolution of antibiotic resistance through environmental switching;Theoretical Ecology;2022-02-10

5. Estimating the Treatment and Prophylactic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the US: A Population Modelling Study;SSRN Electronic Journal;2022